`DIRECTOR
`202-772-8692
`MGILLENTINE@STERNEKESSLER.COM
`
`October 26, 2021
`
`Commissioner for Patents
`PO Box 1450
`Alexandria, VA 22313-1450
`
`Sterne Kessier
`
`
`STEBNE MESSLER GOLDSTEIN & FON
`
`Conf: No. 5661
`
`Re:
`
`U.S. Provisional Patent Application
`Appl. No. 63/257,024; Filed: October 18, 2021
`For.
`DEGRADANT COMPOUNDIN A MEDICAMENT
`First Named Inventor: Rhett Mead SCHIFFMAN
`OurRef:
`4902.0120001
`
`Commissioner:
`
`The following documents are transmitted herewith under 37 C.F.R. § 1.53(c) for appropriate
`action by the U.S. Patent and Trademark Office:
`
`1. Payment made via electronic filing for $50.00 to cover the processing fee (37 C.F.R.
`§ 1.17(q)):
`
`2. Request for Correction in a Patent Application Relating to Inventorship or an Inventor name,
`or Order of Names, Other than in a Reissue Application (37 C.F.R. § 1.48); and
`
`3. An Updated Application Data Sheet, naming as inventors: Rhett Mead SCHIFFMAN and
`Bruce Alan FIRESTONE.
`
`The above-listed documentsarefiled electronically.
`
`Fee paymentis provided through online credit card payment. The U.S. Patent and Trademark
`Office is hereby authorized to charge any fee deficiency, or credit any overpayment, to our Deposit
`Account No. 19-0036.
`
`Respectfully submitted,
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`/Marsha Rose Gillentine, Reg. No. 58,403/
`
`MarshaRose Gillentine
`Attorney for Applicant
`Registration No. 58,403
`
`MRG/B-N/dab
`Enclosures
`17519395_1.docx
`
`Sterne, Keaster, Goldstein & Fox RL, | 0G Mew York Avenue NW | Washington, D.C, 20008
`P 202.871.2800 | F 202.371.2540 | sternekessier.com
`
`